This inventor holds 4 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Genentech, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Innovations by Stephanie Royer Joo
Introduction
Stephanie Royer Joo is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of cancer treatment through her innovative research and development of combination therapies. With a total of 4 patents, her work focuses on enhancing the efficacy of cancer treatments.
Latest Patents
Among her latest patents is a method that combines a KRas inhibitor and a VEGF inhibitor for treating solid tumors. This patent outlines combination therapies that include a KRas inhibitor, such as Compound 1 or its pharmaceutically acceptable salt, along with a VEGF antagonist like bevacizumab. Another notable patent involves the treatment of cancer using combination therapies comprising GDC-6036 and GDC-0077, which details methods for utilizing these compounds to improve cancer treatment outcomes.
Career Highlights
Stephanie Royer Joo is currently employed at Genentech, Inc., where she continues to advance her research in oncology. Her work has been instrumental in developing therapies that target specific pathways involved in cancer progression.
Collaborations
She collaborates with esteemed colleagues, including Mark Merchant and Jennifer Lee Schutzman, to further enhance the impact of her research in the field.
Conclusion
Stephanie Royer Joo's innovative contributions to cancer treatment exemplify the importance of research and collaboration in the medical field. Her patents reflect a commitment to improving patient outcomes through targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile